Abbott Laboratories v. Gardner
387 U.S. 136 (1967)
Facts
In 1962, Congress amended the Federal Food, Drug, and Cosmetic Act to require manufacturers of prescription drugs to print the 'established name' of the drug prominently and in type at least half as large as any proprietary name on labels and other printed material. This amendment aimed to inform doctors and patients that many drugs sold under familiar trade names are identical to those sold under less familiar established names at lower prices.
The Commissioner of Food and Drugs, after proposing regulations and considering comments, promulgated rules requiring the established name to accompany each appearance of the proprietary name in labels, labeling, and advertisements for prescription drugs.
A group of 37 individual drug manufacturers and the Pharmaceutical Manufacturers Association, representing manufacturers of over 90% of the nation's prescription drugs, filed suit challenging these regulations. They argued that the Commissioner exceeded statutory authority by mandating the established name every time the trade name appears. Seeking declaratory and injunctive relief, they claimed the statute did not authorize this 'every time' requirement.
The District Court, on cross-motions for summary judgment, ruled in favor of the plaintiffs, granting the requested relief and finding the regulations exceeded the statute's scope. The Court of Appeals for the Third Circuit reversed, holding that the District Court lacked jurisdiction for pre-enforcement review under the Act and that no actual case or controversy existed. The Supreme Court granted certiorari due to the issue's importance and a conflict with the Second Circuit's decision in Toilet Goods Assn. v. Gardner.
Analysis
Issue #1
Issue
Did Congress intend the Federal Food, Drug, and Cosmetic Act to prohibit pre-enforcement judicial review of regulations like those promulgated by the Commissioner?
Legal Rule
Judicial review of final agency action is presumed available under the Administrative Procedure Act unless there is clear and convincing evidence of congressional intent to preclude it, such as through explicit statutory prohibition or a scheme indicating exclusion of certain actions from review.
Rule Analysis
A survey of cases and the Administrative Procedure Act established a basic presumption of judicial review for those aggrieved by agency action, absent statutory preclusion or commitment to agency discretion. The Act's generous review provisions were to be interpreted hospitably, requiring clear and convincing evidence to restrict access.
No explicit statutory authority prohibited pre-enforcement review here, and the government's reliance on specific review procedures for certain regulations did not imply exclusion of others. Legislative history showed these procedures supplemented traditional remedies like equity suits and declaratory judgments, not replaced them. The saving clause in § 701(f)(6) explicitly preserved other remedies, supporting availability of review. Ewing v. Mytinger & Casselberry was distinguished, as it involved a probable cause finding without the finality or industry-wide impact of these regulations.
Conclusion
No, the Act did not preclude pre-enforcement review of these regulations. The statutory scheme and legislative history indicated that such review was available through traditional channels.
Issue #2
Issue
Was the controversy ripe for judicial review, considering the fitness of the issues for decision and the hardship to the parties if review were withheld?
Legal Rule
Ripeness requires evaluating whether issues are fit for judicial decision (e.g., purely legal, final agency action) and whether withholding review imposes hardship (e.g., direct, immediate impact forcing compliance or risk of penalties).
Rule Analysis
The issue was purely legal—whether the statute authorized the 'every time' requirement—and no further administrative proceedings were contemplated, making it fit for resolution. The regulations constituted final agency action, promulgated formally and effective immediately, akin to reviewable rules in prior cases like Columbia Broadcasting System and Frozen Food Express.
Petitioners faced direct, immediate hardship: compliance required costly changes to labels and materials, while noncompliance risked severe criminal and civil penalties for misbranding. This dilemma, in a sensitive industry, warranted pre-enforcement review to avoid unnecessary harm, consistent with the Declaratory Judgment Act's purpose. Arguments that enforcement depended on the Attorney General (distinguishing from direct agency implementation) or that mere financial expense was insufficient were unpersuasive, as the regulations had the force of law and petitioners had standing.
Concerns about delaying enforcement were addressed by judicial tools like venue transfers, stays, and equitable defenses, without automatic stays of regulations.
Conclusion
Yes, the controversy was ripe for judicial review. The District Court properly entertained the action, and the case was remanded to the Court of Appeals to consider the merits.